Cytosorbents: Pay

Cytosorbents paid its 4 named executives $2.8M in total in FY2025 (Dec). CEO Phillip P. Chan, MD, PhD was paid $808.4K of that.

Pay$100 in the stock at the end of FY20 → $8

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Phillip P. Chan, MD, PhDChief Executive Officer


FY2025 (Dec)							Not disclosed
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Vincent J. Capponi, MSPresident and Chief Operating Officer


FY2025 (Dec)							Not disclosed
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Efthymios N. Deliargyris, MDChief Medical Officer


FY2025 (Dec)							Not disclosed
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Peter J. MarianiChief Financial Officer


FY2025 (Dec)							Not disclosed
FY2024 (Dec)
FY2023 (Dec)							Not disclosed

3 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.